Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 11;6(3):74.
doi: 10.3390/medsci6030074.

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO

James Camp  1 , Jennifer L Cane  2   3 , Mona Bafadhel  4
Affiliations
Review

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO

James Camp et al. Med Sci (Basel). .

Abstract

In an era of precision medicine, it seems regressive that we do not use stratified approaches to direct treatment of oral corticosteroids during an exacerbation of chronic obstructive pulmonary disease (COPD). This is despite evidence suggesting that 40% of COPD patients have eosinophilic inflammation and this is an indicator of corticosteroid response. Treatments with oral corticosteroids are not always effective and not without harm, with significant and increased risk of hyperglycemia, sepsis, and fractures. Eosinophils are innate immune cells with an incompletely understood role in the pathology of airway disease. They are detected at increased levels in some patients and can be measured using non-invasive methods during states of exacerbation and stable periods. Despite the eosinophil having an unknown mechanism in COPD, it has been shown to be a marker of length of stay in severe hospitalized exacerbations, a predictor of risk of future exacerbation and exacerbation type. Although limited, promising data has come from one prospective clinical trial investigating the eosinophil as a biomarker to direct systemic corticosteroid treatment. This identified that there were statistically significant and clinically worsened symptoms in patients with low eosinophil levels who were prescribed prednisolone, demonstrating the potential utility of the eosinophil. In an era of precision medicine our patients' needs are best served by accurate diagnosis, correct identification of maximal treatment response and the abolition of harm. The peripheral blood eosinophil count could be used towards reaching these aims.

Keywords: COPD; Eosinophils; Inflammation.

PubMed Disclaimer

Conflict of interest statement

M.B. has received honoraria and travel expenses for attendance at educational meetings from AstraZeneca, Chiesi, GlaxoSmithKline, Boehringer Ingelheim, Novartis and Pfizer.

Figures

Figure 1
Figure 1
Sputum slide showing eosinophils.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kay A.B. The early history of the eosinophil. Clin. Exp. Allergy. 2015;45:575–582. doi: 10.1111/cea.12480. - DOI - PubMed
    1. Redwan M. Eosinophils, Cytokines, and Allergic Inflammation. Ann. N. Y. Acad. Sci. 1994;725:223–233. - PubMed
    1. Young B. Wheater’s Functional Histology: A Text and Colour Atlas. Elsevier Health Sciences; New York, NY, USA: 2006.
    1. Sanderson C.J. Interleukin-5, eosinophils, and disease. Blood. 1992;79:3101–3109. - PubMed
    1. Luijk B., Lindemans C.A., Kanters D., van der Heijde R., Bertics P., Lammers J.W., Bates M.E., Koenderman L. Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J. Allergy Clin. Immunol. 2005;115:997–1003. doi: 10.1016/j.jaci.2005.02.002. - DOI - PubMed

LinkOut - more resources